Cancer trials support unit (ctsu) IDIQ

Active Awarded Last action

Contract number
75N91022D00009
Awardee
Awarding agency
Task orders
3 $107,118,169 obligated

Award facts

Opportunity
Combined order value
  • $108,993,753 Current, with exercised options
  • $230,733,193 Potential, with all options
Last date to order 85% complete
IDV ceiling 20% used
$548,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 8 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The National Cancer Institute awarded an indefinite-delivery, multiple-award contract to Westat, Inc. with a $548 million ceiling on August 1, 2022. Task areas three, five, and six carry a partial small-business set-aside; the remainder is unrestricted. Performance occurs in Rockville, Maryland. The contract supports operational, administrative, regulatory, information-technology, and logistical services for multi-institutional cancer trials led by NCI-supported clinical trial organizations across six task areas requiring demonstrated experience in oncology clinical research, clinical trial operations, and IT systems. The period of performance runs from August 1, 2022 through July 31, 2032, with an option period extending to July 31, 2027 on the base. NAICS codes 541715 and 541712 and PSC codes R425 and R499 apply. The source identifies three task orders issued under this IDIQ: Task Order 1A/2A for project kick-off and CTSU core support services and enterprise systems, valued at $214.35 million through July 31, 2032, cost-plus-fixed-fee; Task Order 4A for site study setup, valued at $12.3 million through July 31, 2027, cost-plus-fixed-fee; and Task Order 6A for electronic patient-reported outcomes support, valued at $3.99 million through January 31, 2025, cost-plus-fixed-fee. Task Order 4A invoicing shows $1.2 million expended as of FY2024 across 8.5 FTEs and 17,603 contractor hours. The contract is one of multiple awards under the same program; the source names PPD and Technical Resources Inc. as incumbent contractors on other task areas.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00003 · EO14398, RFO, INV, non-commercial BOT modification $0
Other Administrative Action P00002 $0
Supplemental Agreement for work within scope P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N91022D00009?

75N91022D00009 was awarded to Westat, Inc. by National Cancer Institute (National Institutes of Health) on August 1, 2022.

How much is contract 75N91022D00009 worth?

Orders under 75N91022D00009 have obligated $107,118,169. Their combined current value, with exercised options, is $108,993,753. Their combined potential value, with all options, is $230,733,193. 75N91022D00009's own ceiling is $548,000,000.

How many orders have been placed under contract 75N91022D00009?

3 orders have been placed under 75N91022D00009, the latest on August 1, 2022.

Who can order from contract 75N91022D00009?

75N91022D00009 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75N91022D00009 part of a contract vehicle?

Yes. 75N91022D00009 is part of Cancer Trials Support Unit.

Was contract 75N91022D00009 competed?

The extent of competition for 75N91022D00009 was full and open competition. The government received 8 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV